DETECT ALZHEIMERS

Alzheimer’s disease (AD) is a serious and irreversible brain disorder that impairs memory and cognition, progressively worsening to include behavioral changes and an inability to perform simple tasks. AD is the most common cause of dementia; it is estimated that AD affects more than 6 million adults aged 65 years and older in the United States and is projected to affect a staggering ~14 million adults by 2060. AD has a broad impact on the lives of patients and their caregivers, as well as on supporting healthcare and long-term care systems. Although there is no cure for Alzheimer’s Disease early diagnosis, adoption of healthy lifestyle changes, and advancements in Alzheimer’s Disease treatment can be beneficial in helping patients maintain brain health, improve cognitive function, and slow or delay the symptoms of their disease. DETECT Now!

0 Million
Americans ≥65 years old living with AD today
~ 0 Million
(Projected) Americans living with AD by 2060
0
(Estimated) Americans ≥65 years old had Alzheimer's Dementia at death in 2020
0 billion (dollars)
2022 Costs of AD in the US

Less than 1 in 5

Americans are familiar with Mild Cognitive Impairment (MCI)

~1/3

With MCI from AD develop dementia within 5 years of diagnosis

Scientific Council

Liana G. Apostolova, MD, MSc, FAAN

Indiana University Distinguished Professor
Barbara and Peer Baekgaard Professor in Alzheimer's Disease Research
Professor in Neurology, Radiology, Medical and Molecular Genetics
Indiana University School of Medicine
Department of Neurology
Indianapolis, IN

Alireza Atri, MD, PhD

Director, Banner Sun Health Research Institute
Banner Health
Sun City, AZ
Lecturer on Neurology, Center for Brain/Mind Medicine
Brigham and Women’s Hospital and Harvard Medical School
Boston, MA

Brad Dickerson, MD

Director, Frontotemporal Disorders Unit
Massachusetts General Hospital
Professor of Neurology, Harvard Medical School
Boston, MA

Richard M. Dupee, MD, MACP, AGSF

Clinical Professor of Medicine
Tufts University School of Medicine
Clinical professor, Department of Public Health and Community Medicine, Tufts University
Chief, Geriatrics Service, Tufts Medical Center
Senior Physician, Pratt Diagnostic Center
Dean ex officio, Office of International Affairs, Tufts University School of Medicine
Boston, MA

James E. Galvin, MD, MPH

Professor of Neurology
University of Miami Miller School of Medicine
Miami, FL

George T. Grossberg MD

Professor and Director, Division of Geriatric Psychiatry
Department of Psychiatry and Behavioral Neuroscience
Saint Louis University School of Medicine
St. Louis, MO

Scott A. Kaiser, MD

Director of Geriatric Cognitive Health
Pacific Neuroscience Institute
Santa Monica, CA

Diana R. Kerwin, MD, CPI

President, Kerwin Medical Center
Chief, Geriatric Medicine, Texas Health Presbyterian Hospital
Dallas, TX

Marwan Noel Sabbagh, MD, FAAN, CCRI

Professor of Neurology
Alzheimer’s and Memory Disorders Division
Associate Program Director for Research-Neurology Residency
Barrow Neurological Institute
Research Professor, University of Arizona College of Medicine-Phoenix
Clinical Professor of Neurology, Creighton University
Phoenix, AZ

Paul E. Schulz, MD

Rick McCord Professor in Neurology
Umphrey Family Professor of Neurodegenerative Diseases
Director, Neurocognitive Disorders Center
Director, Neurocognitive Disorders Fellowship
McGovern Medical School at UTHealth Houston
Houston, TX

Geoffrey C. Wall, PharmD, FCCP, BCPS

John R. Ellis Distinguished Chair of Pharmacy Practice
Professor of Clinical Sciences
Director, Drake Drug Information Center
Drake University College of Pharmacy and Health Sciences
Internal Medicine Clinical Pharmacist
Iowa Methodist Medical Center
Des Moines, IA

David A. Wolk, MD, FAAN

Professor of Neurology
Director, Penn Alzheimer’s Disease Research Center
University of Pennsylvania
Philadelphia, PA